CME Group Inc [CME] stock prices are up 0.43% to $227.14 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CME shares have lost -0.01% over the last week, with a monthly amount glided 4.12%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
CME Group Inc [NASDAQ: CME] stock has seen the most recent analyst activity on October 08, 2024, when Redburn Atlantic downgraded its rating to a Neutral but kept the price target unchanged to $244 for it. Previously, RBC Capital Mkts started tracking the stock with Sector Perform rating on September 27, 2024, and set its price target to $235. On September 26, 2024, TD Cowen initiated with a Hold rating and assigned a price target of $221 on the stock. BofA Securities downgraded its rating to a Underperform and decreased its price target to $177 on September 03, 2024. JP Morgan downgraded its rating to a Underweight and reduced its price target to $187 on June 21, 2024. Barclays downgraded its rating to Equal Weight for this stock on January 08, 2024, and downed its price target to $222. In a note dated January 03, 2024, Goldman downgraded an Sell rating on this stock but restated the target price of $195.
The stock price of CME Group Inc [CME] has been fluctuating between $190.70 and $230.12 over the past year. Currently, Wall Street analysts expect the stock to reach $213.35 within the next 12 months. CME Group Inc [NASDAQ: CME] shares were valued at $227.14 at the most recent close of the market. An investor can expect a potential drop of -6.07% based on the average CME price forecast.
Analyzing the CME fundamentals
The CME Group Inc [NASDAQ:CME] reported sales of 5.80B for trailing twelve months, representing a surge of 12.67%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.64%, Pretax Profit Margin comes in at 0.74%, and Net Profit Margin reading is 0.57%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.13 and Total Capital is 0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 222.79 points at the first support level, and at 218.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 229.64, and for the 2nd resistance point, it is at 232.14.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 14.11, the price to book ratio is 2.95 and price to earnings (TTM) ratio is 25.05.
Transactions by insiders
Recent insider trading involved SHEPARD WILLIAM R, Director, that happened on Sep 25 ’24 when 280.0 shares were purchased. Director, SHEPARD WILLIAM R completed a deal on Sep 25 ’24 to buy 12.0 shares. Meanwhile, Sr MD Chief Financial Officer Fitzpatrick Lynne sold 754.0 shares on Sep 15 ’24.
